Daymark Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2M | Buy |
81,814
+2,276
| +3% | +$422K | 0.58% | 42 |
|
|
2025
Q1 | $16.7M | Buy |
79,538
+1,145
| +1% | +$240K | 0.72% | 34 |
|
|
2024
Q4 | $13.9M | Sell |
78,393
-807
| -1% | -$143K | 0.59% | 39 |
|
|
2024
Q3 | $15.6M | Buy |
79,200
+2,452
| +3% | +$484K | 0.66% | 37 |
|
|
2024
Q2 | $13.2M | Buy |
76,748
+33,981
| +79% | +$5.83M | 0.6% | 38 |
|
|
2024
Q1 | $7.79M | Sell |
42,767
-260
| -0.6% | -$47.3K | 0.42% | 55 |
|
|
2023
Q4 | $6.67M | Sell |
43,027
-4,008
| -9% | -$621K | 0.41% | 55 |
|
|
2023
Q3 | $7.01M | Buy |
47,035
+6,153
| +15% | +$917K | 0.48% | 49 |
|
|
2023
Q2 | $5.51M | Buy |
40,882
+5,394
| +15% | +$727K | 0.41% | 58 |
|
|
2023
Q1 | $5.66M | Buy |
35,488
+3,655
| +11% | +$582K | 0.75% | 27 |
|
|
2022
Q4 | $5.14M | Buy |
+31,833
| New | +$5.14M | 0.91% | 27 |
|